Efficacy Evaluation of Jinchai Kangbingdu Capsule Based on Coronaryvirus Pneumonia with 'Hanshi Yidu Xifei' syndrome Model

Shan-shan GUO; Dan LI; Yu-jing SHI; Yan-yan BAO; Rong-hua ZHAO; Zi-han GENG; Jing SUN; Lei BAO; Ying-jie GAO; Xiao-lan CUI

doi:10.13422/j.cnki.syfjx.20201401

您当前的位置：

首页 >

文章列表页 >

Efficacy Evaluation of Jinchai Kangbingdu Capsule Based on Coronaryvirus Pneumonia with 'Hanshi Yidu Xifei' syndrome Model

Topic on Epidemic Resistance | 更新时间：2020-08-11

- Efficacy Evaluation of Jinchai Kangbingdu Capsule Based on Coronaryvirus Pneumonia with 'Hanshi Yidu Xifei' syndrome Model
- Chinese Journal of Experimental Traditional Medical Formulae Vol. 26, Issue 13, Pages: 1-7(2020)
- 作者机构：
  
  1.中国中医科学院中药研究所，北京 100700
  2.神威药业集团有限公司，石家庄 051400
- 作者简介：
- 基金信息：
- DOI：10.13422/j.cnki.syfjx.20201401
  CLC： R2-0;R22;R285.5
- Published Online：03 April 2020，
  
  Published：05 July 2020
- 稿件说明：
移动端阅览
郭姗姗,李丹,时宇静等.基于冠状病毒肺炎寒湿疫毒袭肺证病证结合模型的金柴抗病毒胶囊疗效评价[J].中国实验方剂学杂志,2020,26(13):1-7.

GUO Shan-shan,LI Dan,SHI Yu-jing,et al.Efficacy Evaluation of Jinchai Kangbingdu Capsule Based on Coronaryvirus Pneumonia with 'Hanshi Yidu Xifei' syndrome Model[J].Chinese Journal of Experimental Traditional Medical Formulae,2020,26(13):1-7.
郭姗姗,李丹,时宇静等.基于冠状病毒肺炎寒湿疫毒袭肺证病证结合模型的金柴抗病毒胶囊疗效评价[J].中国实验方剂学杂志,2020,26(13):1-7. DOI： 10.13422/j.cnki.syfjx.20201401.

GUO Shan-shan,LI Dan,SHI Yu-jing,et al.Efficacy Evaluation of Jinchai Kangbingdu Capsule Based on Coronaryvirus Pneumonia with 'Hanshi Yidu Xifei' syndrome Model[J].Chinese Journal of Experimental Traditional Medical Formulae,2020,26(13):1-7. DOI： 10.13422/j.cnki.syfjx.20201401.

摘要

目的

在人冠状病毒肺炎寒湿疫毒袭肺证病证结合模型上，研究金柴抗病毒胶囊的治疗作用，为评价其防治冠状病毒感染提供试验依据。

方法

取Balb/c小鼠48只，按体质量随机分为正常组、病毒感染组、寒湿组、寒湿疫毒袭肺证模型组、金柴抗病毒胶囊高、低剂量组（1.76，0.88 g·kg

-1

·d

-1

），采用寒湿刺激加人冠状病毒229E感染模拟人冠状病毒肺炎寒湿疫毒袭肺证的病证结合模型，通过观察Balb/c小鼠行为表征、肺指数、病毒载量、肺组织病理改变来评价金柴抗病毒胶囊的治疗作用；通过酶联免疫吸附测定（ELISA）检测肺组织中白细胞介素-6（IL-6），IL-10，肿瘤坏死因子-

（TNF-

），

干扰素（IFN-

）含量和血清中胃动素(MTL)，胃泌素(GAS)含量，流式细胞术检测外周血中CD4

T细胞，CD8

T细胞，B细胞含量。

结果

与寒湿疫毒袭肺证模型组比较，金柴抗病毒胶囊可增加寒湿疫毒袭肺证小鼠的活动度和反应能力，改善小鼠皮毛和大便状态，金柴抗病毒胶囊高、低剂量组可以显著降低肺指数（

0.01），明显升高CD4

T细胞，CD8

T细胞，B细胞含量（

0.05

0.01）；金柴抗病毒胶囊低剂量组显著降低血清中MTL含量，显著降低肺组织中病毒载量和IL-6，IL-10，TNF-

，IFN-

含量（

0.01），改善肺组织病理损伤。

结论

金柴抗病毒胶囊在人冠状病毒肺炎寒湿疫毒袭肺证模型上具有较好的治疗作用，其可以改善寒湿证的行为表征和胃肠道指标水平，同时减低肺指数和肺组织中病毒载量，改善肺组织病理损伤，初步探讨其机制可能与降低炎症因子含量、提升淋巴细胞数量有关。

Abstract

Objective

To study the therapeutic effect of Jinchai Kangbingdu capsule based on human coronavirus pneumonia with 'Hanshi Yidu Xifei' syndrome model

in order to provide experimental basis for evaluating its effect in preventing and treating coronavirus infection.

Method

The 48 Balb/c mice were randomly divided into normal group

virus infection group

cold-dampness group

cold-dampness epidemic toxin lung syndrome model group

and high and low-dose Jinchai Kangbingdu capsule groups (1.76

0.88 g·kg

-1

·d

-1

). A cold-dampness stimulation combined with human coronavirus 229E infection was used to imitate human coronavirus pneumonia with 'Hanshi Yidu Xifei' syndrome model. Behavioral characteristics

lung index

viral load

and lung tissue pathological changes in Balb/c mice were observed to evaluate the therapeutic effect of Jinchai Kangbingdu capsules. The contents of interleukin-6（IL-6），IL-10，tumor necrosis factor-

（TNF-

），interferon-

（IFN-

） in lung tissue and motilin（MTL），gastrin（GAS） in serum were detected by enzyme-linked immunosorbent assay(ELISA)

and the contents of CD4

T cells

CD8

T cells

and B cells in peripheral blood were detected by flow cytometry.

Result

Compared with the cold-dampness epidemic toxin lung syndrome model group

Jinchai Kangbingdu capsule can increase the activity and response ability of 'Hanshi Yidu Xifei' syndrome model mice

and change the skin and stool status of mice. High and low-dose Jinchai Kangbingdu capsule groups can significantly reduce the lung index (

0.01)

while significantly increased the content of CD4

T cells

CD8

T cells

and B cells (

0.05

0.01). Low-dose Jinchai Kangbingdu capsule group could significantly decrease the MTL content in serum and the levels of IL-6

IL-10

TNF-

IFN-

in lung tissue (

0.01)

whereas alleviate the pathological damage of lung tissue.

Conclusion

Jinchai Kangbingdu capsule showed a therapeutic effect on human coronavirus pneumonia with 'Hanshi Yidu Xifei' syndrome model

and can improve the behavioral characterization and gastrointestinal index level of cold-dampness syndrome

while reduce lung index and viral load in lung tissue. The mechanism may be related to the decrease of the content of inflammatory factors and the increase of the number of lymphocytes.

关键词

Keywords

references

Nature . Coronavirus latest: WHO officially names disease COVID-19 [J]. 2020 , doi: com/articles/d 41586-020-00154-w http://dx.doi.org/com/articles/d 41586-020-00154-w .

国家卫生健康委员会 . 截至 3 月 24 日 24 时新型冠状病毒肺炎疫情最新情况 [EB/OL]. http://www.nhc.gov.cn/xcs/yqtb/202003/b882c06edf184fbf800d4c7957e02dad.shtml http://www.nhc.gov.cn/xcs/yqtb/202003/b882c06edf184fbf800d4c7957e02dad.shtml , 2020-03-24 / 2020-03-27 .

WHO . Novel Coronavirus (COVID-19) Situation [EB/OL]. https://experience.arcgis.com/experience/685d0ace521648f8a5beeeee1b9125cd https://experience.arcgis.com/experience/685d0ace521648f8a5beeeee1b9125cd , 2020-03-25 / 2020-03-27 .

科技部 . 国务院联防联控机制就医疗救治工作进展情况举行发布会 [EB/OL]. http://news.cnfol.com/zhengquanyaowen/20200217/27958348.shtml http://news.cnfol.com/zhengquanyaowen/20200217/27958348.shtml , 2020-02-17 / 2020-03-27 .

古敏 , 刘娇 , 史楠楠 , 等 . 中医药分期防治新型冠状病毒肺炎的药性功效分析 [J]. 中国中药杂志 , 2020 , doi: 10.19540/j.cnki.cjcmm.20200225.501 http://dx.doi.org/10.19540/j.cnki.cjcmm.20200225.501 .

詹志来 , 刘佳 , 杨伟 , 等．基于病例分析的中医药治疗新型冠状病毒肺炎疗效评价标准的探索研究 [J]．中医杂志， 2020 , doi： 11.2166.R.20200312.0949.002.html http://dx.doi.org/11.2166.R.20200312.0949.002.html .

钟菊迎 , 崔煦然 , 崔晓兰 , 等 . 金柴抗病毒胶囊对甲型流感病毒H1N1肺炎模型小鼠的保护作用与机制研究 [J]. 中华中医药学刊 , 2019 , 37 ( 4 ): 894 - 898 .

WHO . WHO Director-General's opening remarks at the media briefing on COVID- 19 - 11 March2020 [EB/OL]. https://www.who.int/dg/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19-11-march-2020 https://www.who.int/dg/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19-11-march-2020 , 2020-03-11 / 2020-03-27 .

杨洋 , 高培阳 , 黄青松 , 等 . 试从中医“疫毒夹湿”探讨新型冠状病毒肺炎（COVID-19）防治思路 [J]. 中药药理与临床 , 2020 , doi: 10.13412/j.cnki.zyyl.20200311.001 http://dx.doi.org/10.13412/j.cnki.zyyl.20200311.001 .

孙良明 , 陈劲松 , 薛燕星 , 等 . 国医大师薛伯寿治疗新型冠状病毒肺炎思路 [J]. 世界中西医结合杂志 , 2020 , doi: 11.5511.R.20200304.1800.002.html http://dx.doi.org/11.5511.R.20200304.1800.002.html .

仕丽 , 刘继民 , 牛崇阳 , 等 . 王檀教授从气化顿滞论治新型冠状病毒肺炎 [J]. 吉林中医药 , 2020 , doi： 10.13463/j.cnki.jlzyy.2020.04.001 http://dx.doi.org/10.13463/j.cnki.jlzyy.2020.04.001 .

王常松 , 吴同玉 , 陈学习 , 等 . 寒湿困脾证动物模型的建立和评价 [J]. 上海中医药大学学报 , 2011 , 25 ( 5 ): 75 - 78 .

HUANG C , WANG Y , LI X , et al . Clinical features of patients infected with 2019 novel coronavirus in Wuhan,China [J]. Lancet , 2020 , 395 （ 10223 ）： 497 - 506 .

XU Z , LI S , TIAN S , et al . Full spectrum of COVID-19 severity still being depicted [J]. Lancet , 2020 , doi: 10.1016/S0140-6736(20)30308-1 http://dx.doi.org/10.1016/S0140-6736(20)30308-1 .

王玉亮 , 王峰 , 耿洁 . 细胞因子与细胞因子风暴 [J]. 天津医药 , 2020 , doi: 12.1116.R.20200311.1245.002.html http://dx.doi.org/12.1116.R.20200311.1245.002.html .

程克斌 , 魏明 , 沈虹 , 等 . 普通型和重型新型冠状病毒肺炎康复患者463例临床特征分析 [J]. 上海医学 , 2020 , doi: 31.1366.r.20200312.1254.004.html http://dx.doi.org/31.1366.r.20200312.1254.004.html .

胡家光 , 蒋忠胜 , 李旭 , 等 . 新型冠状病毒肺炎患者16例外周血T淋巴细胞亚群的变化及意义 [J]. 广东医学 , 2020 , doi: 10.13820/j.cnki.gdyx.20200588 http://dx.doi.org/10.13820/j.cnki.gdyx.20200588 .

Views

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Analysis of Animal Model of Chronic Heart Failure Based on Combination of Diseases and Syndromes of Traditional Chinese Medicine and Western Medicine

Clinical and Animal Experimental Research on Kidney Deficiency Syndrome： A Review

Evaluation of Animal Models of Dilated Cardiomyopathy Based on Clinical Characteristics of Traditional Chinese and Western Medicine

Establishment and Evaluation of Rat model of Cough Variant Asthma with Syndrome of Latent Wind Damaging Yin

Analysis of Animal Models of Cervical Spondylotic Radiculopathy Based on Characteristics of Clinical Symptoms of Chinese and Western Medicine

Related Author

ZHANG Xueyan

ZHANG Kexin

YU You

ZHANG Huan

DUAN Yingzhu

YU Rui

SUN Jianhui

LI Jianliang

Related Institution

The Second Affiliated Hospital of Liaoning University of Chinese Medicine

Liaoning University of Chinese Medicine

Tianjin University of Traditional Chinese Medicine

National Resource Center for Chinese Materia Medica，China Academy of Chinese Medical Sciences

Institute of Chinese Materia Medica，China Academy of Chinese Medical Sciences

AI问答

Postal code：100700
Tel：010-84076882 Email：syfjx_2010@188.com
Technical support is provided by Beijing Founder electronics co., LTD 京ICP备11006657号-10 京公网安备11010802024621
It is recommended to read the content of this site in Chrome&IE9+. Please switch to extreme mode in browser 360.
Cookies We use cookies to help provide and enhance our service and tailor content. By continuing, you agree to the use of cookies.

⁰